Dow Inc.
DOW
$31.25
+2.56%
Dow Inc. is a diversified global chemicals producer, formed in 2019 from the DowDuPont merger, and a leading manufacturer of polyethylene, ethylene oxide, and silicone rubber for consumer and industrial markets. As one of the world's largest chemical companies, it holds a dominant position in commodity and specialty chemicals, with a broad portfolio spanning packaging, infrastructure, and coatings. The current investor narrative centers on the impact of Middle East supply chain disruptions, which have pressured margins and led to a widening loss in Q1 2026, though the company's cost-saving initiatives and optimistic Q2 guidance offer a potential path to recovery. Additionally, the reopening of the Strait of Hormuz has eased geopolitical risk, but lingering petrochemical supply shocks continue to create uncertainty around near-term earnings.…
DOW
Dow Inc.
$31.25
Related headlines
Investment Opinion: Should I buy DOW Today?
Rating: Hold. Dow is a deep-value play with a high dividend yield, but deteriorating fundamentals and negative earnings make it a speculative turnaround story rather than a core holding. The consensus Buy rating and average target of $37.44 suggest upside, but the wide target range and recent downgrades warrant caution.
Supporting Evidence: Dow trades at 0.42x trailing PS, a 60-70% discount to the industry average, and 0.36x forward PS, implying continued revenue decline. Revenue has fallen 6.11% YoY, and the company is unprofitable with a net margin of -4.54%. Free cash flow is negative, and the dividend yield of 8.96% is unsustainably high relative to earnings. The analyst average target implies 25% upside, but the low target of $28 is below the current price, indicating downside risk.
Risks & Conditions: The Hold rating would upgrade to Buy if the company returns to positive net income and FCF, or if the PS ratio compresses below 0.30x, offering a wider margin of safety. It would downgrade to Sell if revenue growth decelerates below -10% YoY or if the dividend is cut. Overall, Dow appears undervalued on a sales basis but fairly valued to overvalued on an earnings basis given negative profits. The stock is a speculative value play for investors with a high risk tolerance and a long-term horizon.
Sign up to view all
DOW 12-Month Price Forecast
Dow's outlook is balanced between a deep-value recovery and a value trap. The base case of gradual improvement is most probable, but the bear case risks are significant given negative earnings and FCF. The stock's low valuation provides a margin of safety, but a catalyst is needed to unlock value. I would upgrade to bullish if the company reports positive EPS and guides for sustained profitability, and downgrade to bearish if revenue continues to decline or the dividend is cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Dow Inc.'s 12-month outlook, with a consensus price target around $36.56 and implied upside of +17.0% versus the current price.
Average Target
$36.56
0 analysts
Implied Upside
+17.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$28 - $48
Analyst target range
Dow is covered by 16 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 2.39 (where 1=Strong Buy, 5=Sell). The average target price is $37.44, implying approximately 25% upside from the current price of $29.92. The distribution shows 10 Buy ratings, 4 Hold, and 2 Sell, leaning bullish overall. The consensus reflects optimism about a potential recovery, though recent downgrades (e.g., RBC Capital from Outperform to Sector Perform) indicate some caution. The target price range spans from a low of $28.00 to a high of $48.00, a spread of $20, indicating high uncertainty. The high target of $48 assumes a strong cyclical recovery, margin expansion, and successful cost initiatives, while the low target of $28 prices in continued supply chain disruptions, margin compression, and potential recession. Recent institutional ratings show a mix of actions: BMO Capital maintained Market Perform, Alembic Global reiterated Overweight, while RBC Capital downgraded from Outperform to Sector Perform. The wide spread and mixed revisions suggest low conviction among analysts, with the stock's fate heavily tied to macroeconomic and geopolitical developments.
Bulls vs Bears: DOW Investment Factors
Dow presents a classic deep-value versus value-trap debate. The bull case rests on historically low valuation (0.42x PS), a consensus Buy rating with 25% upside, easing geopolitical disruptions, and a high dividend yield. The bear case highlights widening losses, declining revenue, negative FCF, and high uncertainty. Currently, the bearish evidence is stronger due to deteriorating fundamentals, but the stock's low valuation and potential cyclical recovery offer a compelling risk/reward for patient investors. The single most important tension is whether the company can return to profitability in the next 12 months, as continued losses would validate the value trap narrative and pressure the stock toward the $28 low target.
Bullish
- Deep Value at 0.42x PS: Dow trades at a trailing PS ratio of 0.42x, a 60-70% discount to the chemicals industry average of 1.0-1.5x. This historically low multiple implies the market is pricing in significant distress, offering a potential value entry if fundamentals stabilize.
- Analyst Consensus Buy with 25% Upside: 16 analysts rate Dow a consensus Buy with an average target of $37.44, implying ~25% upside from the current $29.92. The high target of $48 suggests potential for a 60% rally if a cyclical recovery materializes.
- Geopolitical Risk Easing Supports Recovery: The reopening of the Strait of Hormuz in April 2026 removed a major supply chain disruption that had pressured margins. With petrochemical supply shocks expected to clear over 275 days, input costs should normalize, aiding margin recovery.
- Strong Liquidity and Dividend Commitment: Dow maintains a current ratio of 1.97 and continues its 114-year dividend streak at $0.35/quarter (8.96% yield). Despite negative FCF, the dividend signals management's confidence in a turnaround and provides income support.
Bearish
- Widening Losses and Negative Margins: Q1 2026 net loss widened to $445M from $307M a year ago, with net margin at -4.54%. Gross margin compressed to 6.53% from 6.75%, and operating margin is near zero at 0.65%, indicating severe profitability pressure.
- Declining Revenue Trend: Revenue fell 6.11% YoY in Q1 2026 to $9.79B, continuing a downtrend from $10.43B in Q1 2025. The forward PS of 0.36x implies the market expects further top-line contraction, reflecting weak end-market demand.
- Negative Free Cash Flow and High Leverage: Trailing twelve-month FCF is -$1.395B, and Q1 2026 FCF of $621M barely covers the $252M dividend. Debt-to-equity of 1.22x and negative net income raise concerns about financial flexibility if losses persist.
- High Uncertainty in Analyst Targets: Analyst targets range from $28 to $48, a $20 spread (67% of current price), indicating low conviction. Recent downgrades (e.g., RBC Capital from Outperform to Sector Perform) suggest caution even among bulls.
DOW Technical Analysis
Dow's stock is in a sustained uptrend over the past year, with a 1-year price change of +5.13%, though it has experienced significant volatility. The current price of $29.92 sits at 42.7% of its 52-week range ($20.40 to $42.74), indicating it is closer to the low end of the range after a sharp pullback from highs. This positioning suggests the stock is in a corrective phase, potentially offering a value entry if the downtrend reverses, but also risks further downside if selling pressure persists. Over the past three months, the stock has declined 15.96%, while the one-month change is -7.94%, showing accelerating short-term weakness. This contrasts with the positive 1-year trend, signaling a potential trend reversal or a temporary pullback driven by geopolitical and supply chain headwinds. The relative strength versus the S&P 500 is deeply negative over 1-month (-8.25%) and 3-month (-20.63%), confirming broad underperformance. The 52-week high of $42.74 represents key resistance; a breakout above this level would signal a resumption of the uptrend and could attract momentum buyers. Conversely, the 52-week low of $20.40 is major support; a breakdown below this level would indicate a bearish continuation and potential for further declines. With a beta of 0.44, Dow is significantly less volatile than the market, meaning it tends to move less than the S&P 500, which may appeal to risk-averse investors but also limits upside in rallies.
Beta
0.43
0.43x market volatility
Max Drawdown
-35.5%
Largest decline past year
52-Week Range
$20-$43
Price range past year
Annual Return
+5.4%
Cumulative gain past year
| Period | DOW Return | S&P 500 |
|---|---|---|
| 1m | +1.5% | +0.4% |
| 3m | -18.9% | +5.5% |
| 6m | +10.6% | +8.4% |
| 1y | +5.4% | +18.9% |
| ytd | +28.8% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DOW Fundamental Analysis
Dow's revenue trajectory has been declining, with Q1 2026 revenue of $9.794 billion down 6.11% year-over-year, and the prior four quarters showing a consistent downtrend from $10.431 billion in Q1 2025 to $9.46 billion in Q4 2025. The revenue miss in Q1 was attributed to Middle East supply chain disruptions, which impacted the Packaging & Specialty Plastics segment ($4.919 billion) and Performance Materials & Coatings ($2.08 billion). The declining top line signals end-market weakness and operational challenges, making the investment case dependent on a cyclical recovery or successful cost-cutting. The company is currently unprofitable, with a net loss of $445 million in Q1 2026, compared to a net loss of $307 million in the year-ago quarter. Gross margin has compressed to 6.53% from 6.75% a year earlier, reflecting higher input costs and pricing pressure. Operating margin is near zero at 0.65%, and net margin is -4.54%, indicating that the company is barely covering operating costs and is deeply in the red. The trajectory toward profitability remains uncertain, as losses have widened over the past two quarters. Dow's balance sheet shows a debt-to-equity ratio of 1.22, indicating moderate leverage, and a current ratio of 1.97, suggesting adequate short-term liquidity. However, free cash flow over the trailing twelve months is negative at -$1.395 billion, with Q1 2026 free cash flow of $621 million positive but insufficient to cover the dividend ($252 million paid). The negative FCF yield and reliance on external financing (net debt issuance) raise concerns about financial flexibility, especially if earnings continue to deteriorate.
Quarterly Revenue
$9.8B
2026-03
Revenue YoY Growth
-6.1%
YoY Comparison
Gross Margin
6.5%
Latest Quarter
Free Cash Flow
$-1.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DOW Overvalued?
Since Dow has negative net income (trailing EPS of -$0.16), we use the price-to-sales (PS) ratio as the primary valuation metric. The trailing PS ratio is 0.42x, while the forward PS (based on estimated revenue of $45.62 billion) is approximately 0.36x, implying the market expects revenue to decline further. The gap between trailing and forward PS suggests the market is pricing in continued top-line weakness. Compared to the chemicals industry average PS ratio (typically around 1.0x-1.5x), Dow trades at a significant discount of roughly 60-70%, reflecting its poor profitability and declining revenue. This discount may be justified by the company's negative margins and earnings, but it also suggests that any improvement in profitability could lead to multiple expansion. Historically, Dow's PS ratio has ranged from about 1.6x to 3.8x over the past five years, with the current 0.42x near the bottom of that range. This indicates the stock is trading at historically low valuations relative to sales, which could imply a value opportunity if the business cycle turns, but also reflects the market's pessimism about near-term fundamentals.
PE
-6.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 6x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Dow's primary financial risk is its inability to generate consistent profits, with net losses in three of the last four quarters and a trailing EPS of -$0.16. The company's gross margin has compressed to 6.53%, well below historical levels, and operating margin is near zero, leaving no buffer against further input cost increases or pricing pressure. Negative free cash flow of -$1.395B over the TTM and a debt-to-equity ratio of 1.22x raise concerns about the sustainability of the dividend and the company's ability to invest in growth without external financing. Revenue concentration in cyclical end markets (packaging, infrastructure) amplifies earnings volatility, as evidenced by the 6.11% YoY decline in Q1 2026.
Market & Competitive Risks: Dow's stock has underperformed the S&P 500 by 13.22% over the past year and 20.63% over three months, reflecting deep market pessimism. The stock's beta of 0.44 suggests low correlation to broad market moves, but its high dividend yield (8.96%) may attract income-focused investors, though it also signals elevated risk. Competitive pressures from Middle East producers with lower feedstock costs could persist even after supply chains normalize, keeping margins compressed. Regulatory risks related to environmental policies and potential carbon taxes could further increase costs for a commodity chemical producer.
Worst-Case Scenario: If the global economy enters a recession, chemical demand could weaken further, causing revenue to fall below $9B per quarter and losses to deepen. The stock could retest its 52-week low of $20.40, representing a 31.8% decline from the current price of $29.92. In a severe downturn, the dividend could be cut, triggering further selling. The analyst low target of $28 is only 6.4% below current levels, but a recession could push the stock below that, with historical max drawdown of -35.47% suggesting a potential decline to around $19.30.
FAQ
The key risks are: 1) Financial risk: negative net income and FCF, with a debt-to-equity ratio of 1.22x, could lead to a dividend cut. 2) Competitive risk: Middle East producers with lower costs could keep margins compressed even after supply chains normalize. 3) Macro risk: a recession would further reduce chemical demand, worsening losses. 4) Company-specific risk: the stock's beta of 0.44 means it may not rally with the market, and its high dividend yield could be a value trap if fundamentals don't improve. The most severe risk is a dividend cut, which could trigger a sell-off toward the 52-week low of $20.40.
The 12-month forecast is mixed, with three scenarios: a bull case (25% probability) targeting $37-$48, driven by a strong cyclical recovery and margin expansion; a base case (50% probability) targeting $30-$37, with gradual improvement but flat revenue; and a bear case (25% probability) targeting $20-$28, if losses persist and the dividend is cut. The base case is most likely, assuming the company returns to profitability by late 2026. The analyst average target of $37.44 supports the base case, but the wide range reflects high uncertainty.
Dow appears undervalued on a price-to-sales basis, with a trailing PS of 0.42x versus the industry average of 1.0-1.5x and its own historical range of 1.6-3.8x. However, this discount is justified by negative earnings and declining revenue. On a price-to-earnings basis, the stock is not applicable due to negative EPS. The forward PE of 15.4x based on estimated EPS of $2.29 suggests the market expects a sharp earnings recovery, which is optimistic. Overall, Dow is undervalued relative to sales but fairly valued relative to the risk of continued losses.
Dow is a high-risk, high-reward stock suitable for value-oriented investors with a long-term horizon. The stock trades at a deep discount (0.42x PS) and offers a high dividend yield (8.96%), but the company is currently unprofitable with negative free cash flow. The analyst consensus is Buy with an average target of $37.44, implying 25% upside, but the wide target range ($28-$48) reflects high uncertainty. For risk-tolerant investors who believe in a cyclical recovery, Dow could be a good buy at current levels. However, conservative investors should wait for evidence of sustained profitability before investing.
Dow is better suited for long-term investment (3-5 years) given its cyclical nature and current turnaround phase. Short-term trading is risky due to high volatility (recent 3-month decline of 15.96%) and uncertainty around earnings. The stock's beta of 0.44 means it is less correlated to the market, but its high dividend yield (8.96%) provides income for long-term holders. A minimum holding period of 12-18 months is recommended to allow for a potential cyclical recovery. Short-term traders should focus on technical levels, with support at $27 and resistance at $33.